GalièNHumbertMVachieryJ-Let al.2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J2016; 37: 67–119.
2.
MathaiSCSuberTKhairRMet al.Health-related quality of life and survival in pulmonary arterial hypertension. Ann Am Thorac Soc2016; 13: 31–39.
3.
FukutaHGotoTWakamiKet al.Effects of drug and exercise intervention on functional capacity and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials. Eur J Prev Cardiol2016; 23: 78–85.
4.
De SmedtDClaysEHöferSet al.The use of HeartQoL in patients with coronary heart disease: association with risk factors and European reference values. The EUROASPIRE IV study of the European Society of Cardiology. Eur J Prev Cardiol2016; 23: 1174–1186.
5.
McCabeCBennettMDoughtyNet al.Patient-reported outcomes assessed by the CAMPHOR questionnaire predict clinical deterioration in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Chest2013; 144: 522–530.
6.
Berg SK, Thorup CB, Borregaard B, et al. Patient-reported outcomes are independent predictors of one-year mortality and cardiac events across cardiac diagnoses: Findings from the national DenHeart survey. Eur J Prev Cardiol 2018, https://doi.org/10.1177/2047487318769766.
7.
BaertADe SmedtDDe SutterJet al.Factors associated with health-related quality of life in stable ambulatory congestive heart failure patients: systematic review. Eur J Prev Cardiol2018; 25: 472–481.
8.
YorkeJCorrisPGaineSet al.EmPHasis-10: development of a health-related quality of life measure in pulmonary hypertension. Eur Respir J2014; 43: 1106–1113.
9.
BarstRJChungLZamanianRTet al.Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry. Chest2013; 144: 160–168.
10.
ZanggerGZwislerA-DKikkenborg BergSet al.Psychometric properties of HeartQoL, a core heart disease-specific health-related quality of life questionnaire, in Danish implantable cardioverter defibrillator recipients. Eur J Prev Cardiol2018; 25: 142–149.
11.
RaphaelCBriscoeCDaviesJet al.Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart Br Card Soc2007; 93: 476–482.